This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

US Senate bill hopes to improve USPTO, FDA coordination on drug patents

By Nick Robertson ( March 26, 2025, 20:59 GMT | Insight) -- A bipartisan group of Senators reintroduced the Interagency Patent Coordination and Improvement Act today, a bill that would establish a task force between the US Patent and Trademark Office and Food and Drug Administration to work on prescription drug patents.A bipartisan group of Senators on the Judiciary Committee reintroduced a bill today that would create a task force between the US Patent and Trademark Office and Food and Drug Administration to work on prescription drug patents....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections